The vice president of cell & gene therapy product development at Pacira BioSciences
High-Capacity Adenovirus Vectors for Gene Therapy
Derek Jackson, BS, MA, and Kilian Guse, PhD, of Pacira Biosciences, discussed the company’s symposium at ASGCT 2025.
Evaluating Gene Therapy PCRX-201 for Osteoarthritis of the Knee
Derek Jackson, BS, MA, the vice president of cell & gene therapy product development at Pacira BioSciences, discussed findings related to the immunogenicity of the therapy’s high-capacity adenovirus vector.
Derek Jackson, BS, MA, and Kilian Guse, PhD, on High-Capacity Adenovirus Vectors for Gene Therapy
The vice president of cell & gene therapy product development and the vice president of genetic medicine platforms at Pacira discussed the company’s symposium at ASGCT 2025.
Derek Jackson, BS, MA, on Evaluating Gene Therapy PCRX-201 for Osteoarthritis of the Knee
The vice president of cell & gene therapy product development at Pacira BioSciences discussed findings related to the immunogenicity of the therapy’s high-capacity adenovirus vector.